GovChime
Notice ID: 3bab789f94d7440ea694077817a614e6Award NoticeAwarded

Q301--Renal Diagnostic Testing-Tucson

Awarded on November 28, 2023. Full description on SAM.gov.

Awarded tounder 36C26224C0054 (source: SAM.gov award notice)• $79.7K

Overview

Posted
December 1, 2023
Notice type
Award Notice

Notice details

Place of performance
Tucson VA Heathcare System 3601 S 6th Ave, Tucson, 85723-0001
Last updated
Sep 9, 2025
Award date
Nov 28, 2023
Award amount (SAM.gov award notice)
$79.7K

Identifiers

Solicitation number
36C26224Q0118
Notice ID
3bab789f94d7440ea694077817a614e6
Award number (PIID)
36C26224C0054

Description

The amendment to solicitation shall Correct the notice ID to 36C26224Q0118. Answer interested vendor s questions and post VA s responses below: Please confirm the solicitation # associated with this RFQ, as there are three solicitation numbers listed in the document labeled S02_RFQ_Urgent_Renal_Diagnostic_36C26224Q0118. (36C26224Q0118 is provided on page 1, 36C26224Q0102 is provided under provision 52.212-1; item vii; paragraph one, and 36C26224Q0054 is listed in the same section, paragraph two). VA s response: Refer to i. Correct solicitation/notice ID is 36C26224Q0118. The RFP is for Urgent Anatomic Pathology Lab Services, please describe in detail what is meant by Urgent and what the expectations would be for the vendor. VA s response: Daily local courier pickup, or Priority Overnight FedEx / UPS labels with Mon Sat delivery to vendor, so that the specimen is in their lab, ready to begin testing,  the day after collection. Time requirements for reporting are given in Section 7., C. Testing Results CPT 88312 is a part of a Standard Renal Panel, but is not listed on attachment A, can this CPT# be added to the spreadsheet? VA s response: CPT codes included in Attachment A are based on the testing performed and invoiced in one year by the laboratory currently used by SAVAHCS for renal biopsy testing of a total of 33 cases. It is not intended to limit another laboratory s renal panel to these CPT codes/tests. Another vendor may utilize different / additional tests based on those determined to be necessary by their own nephropathologist(s).  All other terms and conditions remain unchanged. Response are due no later than Tuesday, November 7, 2023 at 7:00 AM Pacific Time.

Full description on SAM.gov

Award Overview

Award Number

36C26224C0054

Award Amount (SAM.gov award notice)

$79.7K

Award Date

Nov 28, 2023

Awardee

Awardee UEI

Q8CENGNQA374

Original Solicitation

Notice ID: 3bab789f94d7440ea694077817a614e6

Posted Date: Dec 1, 2023

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

5
  • 36C26224P0874
    AMERIPATH INC
    Department of Veterans AffairsNAICS 621511
    $160.1KSigned Oct 5, 2026
  • 36C25924A0043
    AMERIPATH INC
    Department of Veterans AffairsNAICS 621511
    —Signed Sep 18, 2026
  • 36C25926N0502
    AMERIPATH INC
    Department of Veterans AffairsNAICS 621511
    $24.6KSigned Sep 18, 2026
  • 36C26224P0874
    AMERIPATH INC
    Department of Veterans AffairsNAICS 621511
    $160.1KSigned Aug 19, 2026
  • 36C25924A0043
    AMERIPATH INC
    Department of Veterans AffairsNAICS 621511
    —Signed Jul 15, 2026

Contacts

Documents

No documents available.

Lifecycle

Solicitation:36C26224Q0118
  1. Combined Synopsis
  2. Awarded

This opportunity has been awarded.

  1. 2×
    Combined SynopsisOct 24, 2023

    Q301--Renal Diagnostic Testing-Tucson

    Notice a62a9e0ccb8743bc9406e121cebe2209 on SAM.gov

  2. AwardedCurrentDec 1, 2023

    Q301--Renal Diagnostic Testing-Tucson

    Notice 3bab789f94d7440ea694077817a614e6 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
The Department of Veterans Affairs, James A. Haley VA Medical Center s (JAHVAMC) intent to solicit sole source to Pacific Edge Diagnostics USA Ltd., for specialized reference laboratory services for Cxbladder molecular diagnostic testing. 1.OBJECTIVE: 1.1 JAHVAMC requires Cxbladder testing for patients with suspected urothelial carcinoma, a history of urothelial carcinoma, or urinary tract abnormalities that cannot be definitively classified by routine morphologic evaluation alone. Cxbladder testing evaluates urinary messenger RNA (mRNA) biomarkers associated with urothelial carcinoma and provides clinically relevant molecular information to support diagnostic clarification, risk stratification, surveillance, and informed treatment decisions. JAHVAMC seeks a firm fixed-price, cost-per-test contract consisting of one 12-month base period and four 12-month option periods. The Contractor shall furnish Cxbladder Triage® and Cxbladder Monitor® testing, including all required test kits, collection and shipping materials, specimen transportation, laboratory analysis, result reporting, technical support, and secure electronic access to finalized test results. 2. SCOPE: 2.1 The Contractor shall furnish all labor, materials, equipment, supplies, shipping services, technical expertise, reporting capabilities, and administrative support necessary to perform Cxbladder Triage and Cxbladder Monitor testing for JAHVAMC, located in Tampa, Florida. Cxbladder Triage and Cxbladder Monitor testing support the clinical evaluation and management of patients who may be at risk for urothelial carcinoma. 2.2 Cxbladder Triage assists clinicians in identifying patients who may require further diagnostic evaluation for urothelial carcinoma. The test supports risk assessment and may help reduce unnecessary invasive diagnostic procedures in patients with a low likelihood of malignancy. 2.3 Cxbladder Monitor supports surveillance of patients with a history of urothelial carcinoma by identifying molecular signals associated with possible recurrent or progressive disease. The test assists clinicians in determining the appropriate level and timing of follow-up evaluation. Determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. 2.4 Important information: The Government is not obligated to, nor will it pay for or reimburse any costs associated with responding to this Special Notice. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. No sub-contracting opportunity is anticipated. The North American Classification System (NAICS) code for this acquisition is 621511 Medical Laboratories with a size standard of $36.5 Million. Any offeror capable of providing this service shall notify the Contracting Officer by email within seven (7) calendar days from the date of the publication of this special notice. *Responses must include written documentation from the OEM, Pacific Edge Diagnostics USA Ltd., showing your company is an authorized service provider. All information is to be submitted no later than 2:00 PM EST, on Tuesday, November 23, 2026, to: keila.president@va.gov.
94%
Special Notice11/23/2026
NO PROPOSALS OR QUOTATIONS ARE REQUESTED AT THIS TIME. THIS PRE-SOLICITATION NOTICE IS FOR INFORMATIONAL PURPOSES ONLY. THE FORMAL RFP WILL BE POSTED AT SAM.GOV UNDER THIS NOTICE NUMBER 36C24227R0003 ON OR ABOUT 10/07/2026. OFFERORS ARE ENCOURAGED TO MONITOR SAM.GOV FOR THE FORTHCOMING RFP AND SUPPORTING DOCUMENTATION. Brief Description of Services: The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 2, on behalf of Veterans Integrated Service Network (VISN) 2 South, intends to issue an RFP - Requirements Contract for comprehensive Reference Laboratory and Esoteric Testing Services. The contract will serve the VA Medical Centers listed in Appendix A. The contractor must provide everything needed to perform all required reference and esoteric laboratory testing. This includes, but is not limited to: All personnel, labor, equipment, transportation, information technology, supplies, and supervision Routine and STAT pickup and transportation of specimens from multiple VA medical facilities to the contractor s laboratory Pre-analytic processing and preservation of samples Performance of laboratory analysis as specified in the contractor s test manual and relevant standards Timely electronic and hardcopy reporting of results to ordering VA facilities, with direct system interface to the VA VistA Laboratory Information System (LIS) Consultation regarding test selection, specimen collection, result interpretation, and specimen requirements Provision of all consumables for specimen collection, preservation, and transport Maintenance of all required certifications and accreditations Compliance with HIPAA and VA information security requirements A complete Statement of Work, with all details and requirements, will be included in the final solicitation. Locations of Service (Appendix A): James J. Peters VA Medical Center VA New Jersey Healthcare System VA Hudson Valley Healthcare System VA New York Harbor Healthcare System Northport VA Medical Center Set-Aside: Unrestricted, this is not Set-Aside. NAICS: 621511 Medical Laboratories
85%
Pre-Solicitation11/30/2026
Special Notice of Intent to Sole Source This is a SPECIAL NOTICE ANNOUNCEMENT ONLY. The Department of Veteran Affairs, VISN 2 Network Contracting Office intends to award a sole source contract for the Northport VAMC, New York. This proposed contract action is for a service in which the Government intends to award a firm fixed-price comprehensive renal pathology biopsy service contract with only one source; Nephrology Associates, PLC dba Arkana Laboratories, 10810 Executive Center Drive, Suite 100, Little Rock, AK 72211 under the authority Federal Acquisition Regulation (FAR) Part 6.302-1 Only One Responsible Source. Places of Performance: Department of Veterans Affairs Northport VAMC Laboratory Department 79 Middleville Road Northport, NY 11768 Purpose and Objectives: The intent of this Special Notice is to identify potential offerors capable of providing comprehensive renal pathology biopsy service for the Laboratory Department at Northport VAMC, New York. General Requirements The contractor shall provide comprehensive renal biopsy pathology and nephropathology reference laboratory services for the evaluation of native and transplant kidney biopsy specimens. Response: Responses to this Special Notice should be able to demonstrate the firm's ability, capability, and responsibility to deliver the service listed above. The purpose of this Special Notice announcement is for market research to make appropriate acquisition decisions and to gain knowledge of potential qualified Service Disabled Veteran Owned Small Businesses, Veteran Owned Small Businesses, 8(a), HubZone and other Small Businesses interested and capable of providing the services described above. Documentation of technical expertise must be presented in sufficient detail for the Government to determine that your company possesses the necessary functional area expertise and experience to compete for this acquisition. No funds have been authorized, appropriated, or received for this effort. Responses should include the following information: Business name, address, business size and Socioeconomic Category (HUBZone, 8(a), Service Disabled Veteran, Small Business, Large Business, etc.), and point of contact to include e-mail address and telephone number. All offerors must be registered in the System for Award Management (www.sam.gov) and Representations and Certifications must be completed prior to any future award. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to provide the full maintenance and repair service on equipment listed. Special Notice Determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Important information: The Government is not obligated to, nor will it pay for or reimburse any costs associated with responding to this sources sought synopsis request. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. No subcontracting opportunity is anticipated. The North American Classification System (NAICS) code for this acquisition is 621511 ($41.5 Million). Any offeror capable of providing this service shall notify the Contracting Officer by email within 14 calendar days from the date of the publication of this Special Notice. All information is to be submitted via e-mail to: Michelle.Harsch@va.gov
85%
Special Notice09/23/2026
This is a Sources Sought Notice only. It is issued solely for information and planning purposes and does not constitute a solicitation. This notice is issued in accordance with Federal Acquisition Regulation (FAR) Part 10, Market Research. The Department of Veterans Affairs (VA) is conducting market research to identify qualified sources capable of providing prostate cancer genomic classifier testing services. The purpose of this notice is to determine the availability of capable businesses and inform an appropriate acquisition strategy. This notice shall not be construed as a commitment by the Government to issue a solicitation or award a contract. Responses are not offers and cannot be accepted by the Government to form a binding contract. The Government will not reimburse any costs associated with responding to this notice. See attached document for details and response requirements.
83%
Market Research11/25/2026
The Department of Veterans Affairs (VA), Network Contracting Office (NCO) 2, on behalf of Veterans Integrated Service Network (VISN) 2 South, intends to issue a formal solicitation for a Requirements contract for comprehensive Reference Laboratory and Esoteric Testing Services. The contract will serve the VA Medical Centers.
83%
Solicitation11/30/2026

Additional Details

Solicitation Number

36C26224Q0118

Archive Date

Jan 30, 2024

Office Address

Gilbert, AZ, 85297